1stBiennial Meeting of Asian Society of Gynecologic Oncology

Date : November 22, 2009
Venue : Toshi Center Hotel Room 701

Opening Address

Opening Address
Date and Time: November 22nd (Sunday) 8:50~
Session Room: Soon Beom Kang
Toshiharu Kamura

Closing Address

Closing Address
Date and Time: November 22nd (Sunday) 17:30~
Session Room: Toshiharu Kamura

Commemoration Lecture from IGCS and SGO

Commemoration Lecture from IGCS and SGO
Date and Time: November 22nd (Sunday) 12:40~13:40
  Global cooperation in gynecologic cancer
Chair: Shingo Fujii (National Hospital Organaization Kyoto Medical Center, Japan)
Speaker: Edward L. Trimble (National Cancer Institute, USA)

Symposium on Cervical Cancer

Symposium on Cervical Cancer
Part 1 Epidemiology and Diagnosis
Date and Time: November 22nd (Sunday) 9:00~10:40
Chairs: Mohammad Farid Aziz
(University of Indonesia, Indonesia) Ikuo Konishi (Kyoto University, Japan)
1. Risk factors of Gynecologic Cancer
Woong Ju
(Department of Obstetrics and Gynecology, School of Medicine, Ewha Womans University, Seoul, Korea)
2. Epidemiology and Screening of Cervical Cancer in Hong Kong
Annie NY Cheung
(Department of Pathology and Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong)
3. Prognostic significance of Serum Vascular Endothelial Growth FactorC (Serum VEGFC) and LymphVascular Space Invasion in Early Stage Cervical Cancer
Heru Priyanto Samadi
(Oncology DivisionDepartment of Obstetrics and Gynecology. Dr. Moewardi Hospital Faculty of Medicine Sebelas Maret Univeristy. Solo. Centre Java. Indonesia)
4. Tumor Necrosis Factoralpha Promoter Polymorphisms in Neuroendocrine Adenocarcinoma of the Uterine Cervix
Chih Long Chang
(Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei Taiwan)
Part 2 HPV Vaccine and Prevention sponsored by Glaxo Smith Kline
Date and Time: November 22nd (Sunday) 10:40~12:00
Chairs: Hee Sug Ryu (Ajou University, Korea)
Hiroyuki Yoshikawa (University of Tsukuda, Japan)
1. Current status of HPV infection and vaccination in Korea
Hyun Hoon Chung
(Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea)
2. Efficacy, Immunogenicity and Safety of HPV16/18 AS04 Adjuvanted Vaccine and Evaluation of CostEffectiveness in Japan
Ryo Konno
(Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan)
3. Celecoxib as a future chemoprevention agent by reduces proliferation, increases apoptosis and tumor size reduction through Cox2PGE2 pathway activity
Supriadi Gandamihardja
(University of Padjadjaran, Bandung, Indonesia)
Part 3 New Trend of Treatment
Date and Time: November 22nd (Sunday) 15:10~17:30
Chairs: Sarikapan Wilailak (Ramathibodi Hospital, Mahidol University, Thailand)
Satoru Sagae (JR Sapporo Hospital, Japan)
1. Laparoscopic management of cervical cancer
JooHyun Nam
(Department of Obstetrics and Gynecology, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea)
2. Laparoscopic Extraperitoneal Paraaortic Lymph Node Dissection in Gynecologic Cancers
Kung Liahng Wang
(Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan)
3. Abdominal radical trachelectomy for invasive cervical cancer patients who desire preserving fertility
Hiroaki Kobayashi
(Dept. of Gynecology and Obstetrics, Graduate School of Medical Scineces, Kyushu University, Fukuoka, Japan)
4. Evolving Radiotherapy in Cervical Cancer; from 2D to 4DIGRT
Chomporn Sitathanee
(Radiation Oncology Division, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand)
5. Are we justified for concomitant chemoradiation in Advanced Stage Cancer Cervix?
Shyam Kishore Shrivastava
(Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India)
6. New Trends of Treatment for Cervical Cancer: The Singapore Experience: the use of the GOG score to tailor postop management for early stage cervical cancer
Chia Yin Nin
(Department of Gynaecologic Oncology, KK Women's and Children's Hospital, Singapore)